Pityriasis rosea is a common rash that usually begins as a round or oval-shaped patch and spreads in stages in a characteristic pattern. 2022 Jan;114:88-89. doi: 10.1016/j.ijid.2021.10.055. Cutaneous adverse reactions of COVID-19 vaccines: A systematic review. doi: 10.1111/bjd.20143. In an American study, the average latency time was 13 days.7 In the previous cited Turkish-Egyptian study, the average latency time was 12.7 days.17 In 22 cases the eruption appeared 1-21 days after the second dose (average: 8.8 days); in 2 cases the eruption occurred both after the first and the second dose. HHS Vulnerability Disclosure, Help and transmitted securely. [Epub ahead of print]. McMahon DE, Amerson E, Rosenbach M, Lipoff JB, Moustafa D, Tyagi A, Desai SR, French LE, Lim HW, Thiers BH, Hruza GJ, Blumenthal KG, Fox LP, Freeman EE. (2021) p. e15040. It may or may not be itchy and usually lasts six to eight weeks before resolving on its own. Epub 2021 Nov 2. Herald patch in the right hypochondrium followed by typical oval-shaped secondary plaques, Pityriasis rosea lesions on the upper extremities, MeSH pityriasis rosea after covid vaccine Last month at Barret-jackson in Scottsdale, Arizona a 1929 Roadster was put up for sale by Dave Kindig of . Epub 2021 Jul 21. doi: 10.1111/jdv.17316, PubMed Abstract | CrossRef Full Text | Google Scholar, 2. Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review. 2022 May;121(5):1003-1007. doi: 10.1016/j.jfma.2021.12.028. doi: 10.1111/jdv.12942, 13. 2022 Sep-Oct;40(5):586-590. doi: 10.1016/j.clindermatol.2022.01.002. HHS Vulnerability Disclosure, Help J Am Acad Dermatol. eCollection 2022 Jul. 2022 Aug;35(8):e15602. Cutaneous Sarcoidosis-like Eruption Following Second Dose of Moderna mRNA-1273 Vaccine: Case or Relationship? Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. The following self-care tips may help relieve the discomfort of pityriasis rosea: Take nonprescription allergy medicine (antihistamines), such as diphenhydramine (Benadryl, others). A history of viral infection preceding the disease was reported 2022 Feb 3;9 (2):003164. doi: 10.12890/2022_003164. doi: 10.7759/cureus.27108. All patients are currently in good general health. Int J Dermatol. sharing sensitive information, make sure youre on a federal 2 min read January 12, 2022 - 6:26AM A Sydney-based woman has credited her booster dose of the Covid-19 vaccine with removing two persistent warts she's had for five years. Bookshelf and transmitted securely. COVID-19 has been reported as one such viral trigger for PR. The site is secure. Bookshelf eCollection 2023 Mar-Apr. Cutis. Federal government websites often end in .gov or .mil. Dermatol Ther. All patients were treated with cetirizine (20 mg/day for 7-14 days). Four patients were subjected to the second vaccination, but no skin lesions appeared. However, the etiopathogenetic mechanisms remain largely unknown and further studies are needed in order to clarify the correlation between SARS-CoV-2 and PR. The study is created by eHealthMe and uses data from the Food and Drug Administration (FDA). Careers. Due to the rising incidence of coronavirus disease 2019 (COVID-19) worldwide, mass vaccination has been the cornerstone in preventing viral spread and decreasing morbidity and mortality. -, Carballido Vzquez AM, Morgado B. Pityriasis rosea-like eruption after PfizerBioNTech COVID-19 vaccination. Disclaimer. Here, we report the first case of PR-like eruption following ChAdOx1 nCoV-19 (Oxford/AstraZeneca) vaccination. Polack FP, Thomas SJ, Kitchin N et al. Veraldi S, Boneschi V, Cusini M, Maronese CA. Spongiotic dermatitis was the most commonly reported cutaneous reaction to COVID-19 vaccination among patients who also had biopsy results available for review, according to a registry-based. Although the exact pathogenesis of PR is unknown, current evidence suggests that an inflammatory reaction due to a viral trigger may lead to the cutaneous manifestations. Cazzato G, Ambrogio F, Foti C, Capuzzolo M, Trilli I, Casatta N, Lupo C, Carrieri M, Daini D, Colagrande A, Maiorano E, Ingravallo G. Diagnostics (Basel). Literature data about PR/PRLE after anti-SARS-CoV-2 vaccination may be summarized as follows: i) the infection occurs both in males and females (in several articles the gender was not reported); ii) the age ranges from 19 to 82 years (the count of the mean age is impossible because in several articles patients age was not specified). This article presents a case of PR in a 66-year-old black male 1 week after administration of the Pfizer-BioNTech COVID-19 vaccine. Treatment with topical 0.1% triamcinolone acetonide twice daily showed partial response after seven days. The association between pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccines was established, but given the scarcity of studies, there is a need to conduct different clinical trials to confirm this association further and study the etiology and mechanism of the disease. 2021 Oct;20(10):3080-3084. doi: 10.1111/jocd.14372. In the period May 2021- February 2022 we observed five cases of clinically typical PR that appeared 2 to 3 weeks after anti-SARS-CoV-2 vaccination with BNT162b2 (3 patients) or mRNA- 1273 (2 patients). J Formos Med Assoc. It has been suggested that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces reactivation of other viruses, such as HHV-6, HHV-7, varicella zoster virus, and Epstein-Barr virus (5). Potassium hydroxide, syphilis, and laboratory tests were within normal limits. 2023 Apr;11(4):e804. The vaccination campaign has been the most important strategy to combat the COVID-19 pandemic. McMahon DE, Kovarik CL, Damsky W, et al.. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: a registry-based study. and transmitted securely. Federal government websites often end in .gov or .mil. The mechanisms behind these COVID-19-related symptoms remain unclear. Ciccarese G, Parodi A, Drago F. SARS-CoV-2 as possible inducer of viral reactivations. An official website of the United States government. Perivascular lymphocytic infiltrates with some extravasated erythrocytes were observed in the superficial dermis (Figure 2). eCollection 2023 Mar 7. Accessibility Tina Burke, 40, a nurse who works on the oncology floor at Massachusetts General Hospital (MGH), received her first coronavirus shot on Jan. 3. Please enable it to take advantage of the complete set of features! These types cannot cause cold sores or genital herpes. 2021 Nov;35(11):e721-e722. Disclaimer. sharing sensitive information, make sure youre on a federal SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19. In 4 patients PR appeared after the first vaccination; in one patient after the second one. The https:// ensures that you are connecting to the Pityriasis rosea after mRNA COVID-19 vaccination. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). Herald patch is often absent. As a library, NLM provides access to scientific literature. Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male. . Careers. Apply a moisturizer, calamine lotion or a nonprescription . Dermatol Ther. 2021;85(1):4655. doi: 10.1016/j.jaad.2020.04.094, 8. Careers. Khan I, Elsanousi AA, Shareef AM, Tebha SS, Arif A, Gul S. Immun Inflamm Dis. FOIA All patients are currently in good general health. However, there are limited data on the negative effects of immunological reactivation following vaccination. doi: 10.12998/wjcc.v5.i6.203, 6. Nicotinamide does not prevent skin cancer in solid organ transplant recipients (March 2023) URTICARIA AND ANGIOEDEMA. National Library of Medicine See All You will learn Airbrushing, Pinstriping, and Woodgrain. The rash most often appears on the chest, back, and belly. (A) Dermoscopic features: dotted and linear vessels forming a network on a yellowish background with some whitish peripheral scales (original magnification x20). Veraldi S, Boneschi V, Cusini M, Maronese CA. Vaccinations have been identified to rarely cause several cutaneous reactions. The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author/s. The pathogenesis of this relationship is unknown. Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin. 8600 Rockville Pike Although it is known that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be associated with skin manifestations, a limited number of images are available in the literature at this time. eCollection 2023 Mar 7. A 3-cm oval plaque with peripheral scale, larger, MeSH The rash can be itchy. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases. In the period May 2021- February 2022 we observed five cases of clinically typical PR that appeared 2 to 3 weeks after anti-SARS-CoV-2 vaccination with BNT162b2 (3 patients) or mRNA- 1273 (2 patients). The site is secure. An official website of the United States government. MeSH Pityriasis rosea (PR) is an acute, exanthematous disease likely caused by human herpesvirus (HHV)-6 and/or HHV-7. Unable to load your collection due to an error, Unable to load your delegates due to an error. McMahon DE, Amerson E, Rosenbach M, et al.. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. Treatment with topical 0.1% triamcinolone acetonide twice per day showed partial response after seven days. The most commonly inoculated vaccines include those against smallpox, followed by tuberculosis, poliomyelitis, influenza, and human papillomavirus virus (12, 13). It then causes many more small patches. We present a case of a pityriasis rosea-like rash occurring after Pfizer COVID-19 vaccination and review cases of pityriasis rosea (PR)/PR-like eruption (PR-LE) after mRNA COVID-19 vaccine published in the medical literature. Martora F, Battista T, Marasca C, Genco L, Fabbrocini G, Potestio L. Clin Cosmet Investig Dermatol. Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine. 2021 Sep;35(9):e546-e548. This site needs JavaScript to work properly. The https:// ensures that you are connecting to the Due to the rising incidence of coronavirus disease 2019 (COVID-19) worldwide, mass vaccination has been the cornerstone in preventing viral spread and decreasing morbidity and mortality. Br J Dermatol. official website and that any information you provide is encrypted Although the exact pathophysiologic mechanisms of PR after vaccination remain unclear, immune responses to COVID-19 vaccines and disruption of T-cell mediated control of latent infections were implicated (12, 1518). Please enable it to take advantage of the complete set of features! Epub 2022 Mar 8. Careers. It starts with one large round or oval scaly patch. 2022 May;35(5):e15391. As our patient did not receive a COVID-19 vaccine, we cannot evaluate the latter based on the present case. The face may be involved; involvement of the oral cavity occurs in 50% of patients. Numerous scattered erythematous, Pityriasis rosea. In 4 patients PR appeared after the first vaccination; in 1 patient after the second one. Results: An official website of the United States government. All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Variable dermatological manifestations including acral erythema, urticaria, vasculitis, vesicular or pustular eruptions, maculopapular rash have all been reported during the course of COVID19. He described the appearance of an erythematous centrally scaled lesion at the right part of his abdomen, followed by the spreading of red oval mildly scaling lesions on the trunk, neck, and proximal parts of the upper extremities, which showed in the physical examination (Figure 1, a and b). The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). The ones found in people with pityriasis rosea are human herpesviruses 6 and 7. Suchonwanit P, Rojhirunsakool S, Khunkhet S. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia. Wien Med Wochenschr. 2022 Nov 6;15:2369-2382. doi: 10.2147/CCID.S388245. Dermatol Reports. -, Drago F, Ciccarese G, Parodi A. Pityriasis rosea and pityriasis rosealike eruptions: how to distinguish them? Conclusions: We report a spectrum of cutaneous reactions after mRNA COVID-19 vaccines. -, Welsh E, Cardenas-de la Garza JA, Cuellar-Barboza A, Franco-Marquez R, Arvizu-Rivera RI. Pityriasis rosea and pityriasis rosea-like eruptions: how to distinguish them? An official website of the United States government. Before . doi: 10.1111/jdv.17498. We observed Pityriasis rosea (PR)-like eruption is a cutaneous complication associated with several medications and vaccinations. . J Med Virol. HHS Vulnerability Disclosure, Help 2022 Jun;7:164-168. doi: 10.1016/j.jdin.2022.01.009. Ehsani AH, Nasimi M, Bigdelo Z. Pityriasis rosea as a cutaneous manifestation of COVID-19 infection. While COVID-19 vaccines offer strong and lasting protection against severe . CONCLUSION: The association between pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccines was established, but given the scarcity of studies, there is a need to conduct different clinical trials to confirm this association further and study the etiology and mechanism of the disease. Temiz SA, Abdelmaksoud A, Dursun R, et al.. Pityriasis rosea following SARSCoV- 2 vaccination: a case series. 2021;35(9):e546e548. Clipboard, Search History, and several other advanced features are temporarily unavailable. Bookshelf Copyright 2021 Leerunyakul, Pakornphadungsit and Suchonwanit. Khan I, Elsanousi AA, Shareef AM, Tebha SS, Arif A, Gul S. Immun Inflamm Dis. Dermatol Reports. Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature JAAD Int. Pityriasis rosea. Epub 2022 Jun 13. Epub 2021 May 29. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID19). reactions included pernio/chilblains, cosmetic ller reactions, zoster, herpes simplex ares, and pityriasis rosea-like reactions. The https:// ensures that you are connecting to the Reply to "the significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations" by Ciccarese G. et al. Children often get infected when someone sneezes or kisses them. 2022 Nov-Dec;67(6):802-804. doi: 10.4103/ijd.ijd_562_22. An official website of the United States government. Four patients were subjected to the second vaccination, but no skin lesions appeared. Gianotti-Crosti Syndrome is a rare skin disease affecting children at the first years of age. Federal government websites often end in .gov or .mil. Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance. It can take 1 to 3 months to go away. doi: 10.1111/dth.13878, 10. Vaccine-Related Eruptions of Papules and Plaques Following COVID-19 Vaccination - A Case Series. Careers. doi: 10.1159/000517971. The four stages of pityriasis rosea are: Preliminary stage: You feel ill for a day or two. Unable to load your collection due to an error, Unable to load your delegates due to an error. (2020) 33:e13878. Abdullah L, Hasbani D, Kurban M, Abbas O. Pityriasis rosea after mRNA COVID-19 vaccination. Dermatol Ther. It manifests as oval-shaped, pink or red . JAAD Case Rep. 2021;7:9394. Dermatol Ther. Book appointments online with Optimized Health and Wellness of Hudson, FL. COVID-19 vaccine hesitancy is a critical problem that hinders Unauthorized use of these marks is strictly prohibited. With COVID-19 vaccines being authorized for emergency use, monitoring for potential adverse effects (e.g., cutaneous reactions) is necessary. J Eur Acad Dermatol Venereol. HHS Vulnerability Disclosure, Help Bethesda, MD 20894, Web Policies Therefore, this study will systematically review its manifestation afteradministration. PRISMA flowchart. The .gov means its official. government site. Among patients who received COVID-19 vaccines, PR-like eruptions have been reported following the first (n = 1) or second dose (n = 2) of BNT162b2 mRNA-based vaccines (3, 4). 18. J Eur Acad Dermatol Venereol. Due to the temporal relationship between vaccination and onset of rash, COVID-19 vaccination was the most likely etiology. Dermatol Reports. and transmitted securely. Previously, PR has been reported in temporal association with various viral inoculations. Suchonwanit P, Leerunyakul K, Kositkuljorn C. Diagnostic and prognostic values of cutaneous manifestations in COVID-19. Alvin Friedman-Kien, MD, walked through the doorway into the exam room, looked at me and immediately said, "Oh, you have pityriasis rosea." He called in a bunch of residents so he could show them my rash and teach them about the condition, which often has a large patch called the "mother patch" (or herald patch), as well as smaller . National Library of Medicine The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Pityriasis rosea (PR)-like eruption is a rare cutaneous complication of immunization. Br J Dermatol 2021. Federal government websites often end in .gov or .mil. Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine Pityriasis rosea (PR) is an acute papulosquamous cutaneous disorder that classically presents with a herald patch rapidly followed by a widespread rash along skin cleavage lines. To the best of our knowledge, only one case of ChAdOx1 nCoV-19 vaccine-induced PR-like eruption has been reported (2). National Library of Medicine Numerous scattered erythematous plaques with fine scale oriented along skin cleavage, Herald patch of pityriasis rosea. doi: 10.1111/bjd.20143. PMC Peripheral eosinophilia is often present. It is usually seen in children, adolescents, and young adults. Keywords: adverse effect, coronavirus, cutaneous eruptions, immunization, pityriasis rosea, SARS-CoV-2, vaccine, case report, Citation: Leerunyakul K, Pakornphadungsit K and Suchonwanit P (2021) Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination. However, in cases of atypical PR, it may present with erythema multiforme-like lesions and purpura (5). A 52-year-old Thai woman with a one-year history of recurrent glioblastoma was admitted to our hospital for a planned targeted therapy. Clin Dermatol. The experience on a case of Pityriasis Rosea diagnosed after Covid 19 infection with atypical clinical presentation and low responsiveness to conventional treatments is shared. Dermatol Ther. 2021 Dec;108(6):317-318. doi: 10.12788/cutis.0411. The cause of pityriasis rosea is not known, but it is commonly believed to be caused by a virus or bacteria. 2022 Nov 6;15:2369-2382. doi: 10.2147/CCID.S388245. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine. Clipboard, Search History, and several other advanced features are temporarily unavailable. Urbina F, Das A, Sudy E. Clinical variants of pityriasis rosea. 2023 Mar 29;13(7):1286. doi: 10.3390/diagnostics13071286. Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report. The site is secure. Conflicts of Interests: The authors declare there are no competing interests. Complete remission was observed within 14-30 days. Federal government websites often end in .gov or .mil. However, after 14 days, she developed multiple discrete blanching erythematous oval patches and plaques on the lower abdomen, back, and bilateral upper thighs (Figures 1A,B). Moreover, COVID-19 may solely induce human herpesvirus reactivation through the immunomodulatory ability of SARS-CoV-2 to reactivate latent viruses (8, 9). Keywords: doi: 10.1111/jdv.17301. "Covid arm," a red, rashlike skin reaction that can occur at the injection site days after inoculation, has been well-publicized. A number of vaccines have been produced to combat the current COVID-19 pandemic, and a variety of side effects have been recorded following the vaccination. COVID-19; HHV, human herpes virus; Moderna; PR; PR, pityriasis rosea; PR-LE; PR-LE, pityriasis rosea-like eruption; Pfizer; coronavirus; dermatology; mRNA vaccine; mRNA, messenger RNA; pityriasis rosea; pityriasis rosealike eruption; vaccine. J Eur Acad Dermatol Venereol. Before Bethesda, MD 20894, Web Policies Unauthorized use of these marks is strictly prohibited. Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine. Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review. 2021;184(6):11941195. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine. doi: 10.1111/j.0022-202X.2005.23719.x. The authors of one 2014 case report of a 71-year-old man who suffered from pityriasis rosea one month after receiving an influenza vaccine concluded that "altered immunity" could result in. Epub 2021 Aug 7. Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccination. Department of Pathophysiology and Transplantation, Universit degli Studi, Foundation IRCCS Ca Granda Ospedale Maggiore Policlinico, Milan, Italy. Oral baricitinib for moderate to severe alopecia areata in adolescents . It is possible that a relationship between anti- Sars-CoV-2 vaccination and PR/PRLE exists; however, it is very rare, in consideration of millions of vaccinated subjects and the low number of reported cases of PR/PRLE. 2022 Nov 1;43(6):555-558. doi: 10.2500/aap.2022.43.220058. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Pityriasis is linked mainly with herpesviruses 6 and 7; only a . However, pityriasis rosea is a selflimiting benign exanthema and does not require . Several vaccines have been created to counteract the morbidity and mortality associated with COVID19 and stop viral transmission, including the Moderna vaccine (Mrna1273).The mRNA1273 vaccine is a lipid nanoparticle-encapsulated mRNAbased vaccine that encodes the prefusion stabilized fulllength spike . doi: 10.1007/s10103-019-02783-8, 16. Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions: a review of the literature. Pityriasis rosea (PR) is an acute papulosquamous cutaneous disorder that classically presents with a herald patch rapidly followed by a widespread rash along skin cleavage lines. It was found popularly in the trunk area, either asymptomatically or with mild symptoms. Morphologic misclassication is possible. Among the common cutaneous manifestations of COVID-19 (e.g., morbilliform eruptions, chilblains, and varicella-like vesicles), PR and PR-like eruptions have rarely been described (6, 7). Veraldi S, Boneschi V, Cusini M, Maronese CA. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (, Anti-SARS-CoV-2, AZD1222, BNT162b2, mRNA-1273, Pityriasis rosea, Pityriasis rosea-like eruption. Human herpesvirus-6,7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19. N Engl J Med 2020; 383: 2603-2615. Accessibility Then you may get smaller spots that sweep out from the middle of the body in a shape that looks like drooping pine-tree branches. Pityriasis versicolor is another common skin condition that can be confused with pityriasis rosea, as the rash may look similar. Pityriasis rosea is a common viral infection that usually affects individuals between 10-35 years of age. Marcantonio-Santa Cruz OY, Vidal-Navarro A, Pesqu D, Gimnez-Arnau AM, Pujol RM, Martin-Ezquerra G. J Eur Acad Dermatol Venereol. Background: After introducing Covid-19 vaccines, a few side effects were reported, pityriasis rosea being one of them.Therefore, this study will systematically review its manifestation afteradministration.Methods: Databases were searched, covering a timeline from December 1, 2019 to February 28, 2022.Data were independently extracted and accessed for bias. 2022 Jul 21;14(7):e27108. 2020;96(1142):753758. National Library of Medicine Zhongguo Dang Dai Er Ke Za Zhi. Erin Riley said she made the discovery two weeks after receiving a mRNA Covid vaccine, which currently include Pfizer-BioNTech or Moderna. Dermatology. doi: 10.1111/jdv.17342. Unlike in our patient, oropharyngeal lesions were observed in approximately 16% of patients with typical PR (10). Drago F, Ciccarese G, Javor S, Parodi A. Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions: a review of the literature. Background: The. Pityriasis rosea (PR)-like eruption is a cutaneous complication associated with several medications and vaccinations. Pityriasis rosea developing after COVID-19 vaccination. Front. official website and that any information you provide is encrypted Despite this rare complication, our report highlights that the presence of PR-like eruption is not a contraindication for subsequent vaccinations. JAAD Case Rep. (2018) 4:8001. The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Martora F, Picone V, Battista T, Fabbrocini G, Marasca C. Dermatol Ther. Databases were searched, covering a timeline from December 1, 2019 to February 28, 2022. These findings were consistent with a diagnosis of PR-like eruption. Cases of pityriasis rosea/pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination reported in the literature. The authors declare no conflict of interest. There are four main types of vaccines and over 240 candidate vaccines in development. See this image and copyright information in PMC. Pityriasis rosea (PR), PR-like eruptions (PR-LE), and herpes zoster have been frequently reported during the COVID-19 pandemic and following COVID-19 vaccination. (2016) 30:5445. Among patients who received inactivated vaccines, another case of PR-like eruption was reported four days after the first dose of CoronaVac (SinoVac) (1). Disclaimer. eCollection 2021. If so, the reason may be simple: in several countries, BNT162b2 is the most used vaccine; iii) in 55 cases the rash was classified as PR, in 6 cases as PRLE; iv) in 39 cases the eruption appeared 1-12 days after the first dose (around: 4.8 days). Clipboard, Search History, and several other advanced features are temporarily unavailable. doi: 10.1111/ijd.15700, 4. They described a patient developing pityriasis rosea (PR) 2 hours after the second dose of Moderna COVID-19 vaccination. In a Spanish study,PR/PRLE was observed in 11 patients (6.7%) vaccinated with BNT162b2, in 5 patients (3.4%) vaccinated with mRNA- 1273 and in 4 patients (4.2%) vaccinated with AZD1222.2 Available data suggest that BNT162b2 vaccine is more related to PR/PRLE than other vaccines. Disclaimer. An official website of the United States government. Central dusky-red erythematous on some plaques (A); almost all lesions fading with associated post-inflammatory hyperpigmentation after treatment (B). Physical examination revealed that lesions were distributed along cleavage lines, similar to PR, without herald patch or prominent scales (Figure 1C). J Eur Acad Dermatol Venereol. J Formos Med Assoc. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work. 8:752443. doi: 10.3389/fmed.2021.752443. J Med Virol 2021; 93: 1850-1851. Federal government websites often end in .gov or .mil. Methods: 2021 Sep;60(9):1150-1151.doi: 10.1111/ijd.15700. Since you said you felt ill at the time getting the vaccine you had covid at the time.
pityriasis rosea after covid vaccine